Tribune News Service
Rohtak, July 10
The Post Graduate Institute of Medical Sciences (PGIMS) has administered BCG (Bacillus Calmette Guerin) vaccination to 175 attendants of COVID-19 sufferers to see whether or not or not it proves to be efficient in combating the virus.
In this scientific trial, shut contacts of sufferers, medical doctors, nurses, ward boys and sanitary staff have been administered the vaccine. The trial was kicked off on May 1.
All 175 individuals have been saved underneath statement for 180 days. During this era, the impact of the vaccine can be studied in phases.
A cell phone utility has additionally been developed to obtain suggestions about their well being at common intervals. The members have been requested to tell medical doctors in the event that they fall sick or if there’s a swelling on the spot the place the vaccine was administered. Mobile numbers of medical doctors have additionally been shared with the members.
“Blood samples of all participants will be taken for the antibody test after the completion of the observation period. The latest level of antibody of participants will be compared to the level of antibody recorded before administering the BCG vaccine. The vaccine will be considered effective if the level of antibody is higher before administering the vaccine,” mentioned Dr Ramesh Verma, a co-investigator within the scientific trial and professor within the Department of Community Medicine on the PGIMS.
Dr Dhruv Choudhry, investigator of the analysis and head of the pulmonary and important care drugs on the PGIMS, mentioned the BCG vaccine enhanced the immunity and was used in opposition to tuberculosis, nevertheless it additionally possesses the power to induce potent safety in opposition to different infectious ailments.
“The clinical trial aims at exploring whether or not the participants get infected from COVID-19. If yes, we want to know the intensity of severity. If no, it will prove that the vaccine is effective,” mentioned Choudhary, who can also be the state coordinator for the COVID Control Programme.